CBP is a transcriptional coactivator required by many transcription factors for transactivation. Rubinstein-Taybi syndrome, which is an autosomal dominant syndrome characterized by abnormal pattern formation, has been shown to be associated with mutations in the Cbp gene. Furthermore, Drosophila CBP is required in hedgehog signaling for the expression of decapentapleigic, the Drosophila homologue of bone morphogenetic protein. However, no direct evidence exists to indicate that loss of one copy of the mammalian Cbp gene affects pattern formation. Here, we show that various abnormalities occur at high frequency in the skeletal system of heterozygous Cbp-deficient mice resulting from a C57BL͞6-CBA ؋ BALB͞c cross. In support of a conserved signaling pathway for pattern formation in insects and mammals, the expression of Bmp7 was found to be reduced in the heterozygous mutants. The frequency of the different abnormalities was significantly lower in a C57BL͞6-CBA background, suggesting that the genetic background is an important determinant of the variability and severity of the anomalies seen in Rubinstein-Taybi syndrome patients.A protein that binds to the protein kinase A-phosphorylated form of cyclic AMP response element-binding protein (CREB) was originally identified and named CBP (1). CBP also binds to several components of the basal transcriptional machinery, including transcription factor IIB (2), RNA polymerase II holoenzyme complex (3), and the GCN5-like histone acetyltransferase, P͞CAF (4), suggesting that CBP serves as a CREB coactivator. In addition, CBP binds to multiple kinases, such as S6 kinase pp90 RSK (5) and cyclin-dependent kinases (6), and mediates the regulation of transcription by these kinases. The recent finding that CBP itself has histone acetyltransferase activity (7,8) suggests that it contributes to transcriptional activation by disrupting the repressive chromatin structure. CBP interacts with not only CREB but also with many other transcription factors,